India is the biggest manufacturer and exporter of generic drugs on globe and considered as the pharmacy of the globe. However many Indian pharma companies find it difficult to survive in global markets due to the heavy competition, lack of market research knowledge, complex regulatory results and not embracing the latest digital technologies adopted by global companies.
Innovation brings both opportunity and change, and this is true with emerging point of care technology. There is a pressing need for help in the three critical areas of Prevention, Diagnosis and Monitoring.But extremely restrictive regulations, the presence of multiple key stakeholders, a slow-to-adopt culture and other challenges distinguish healthcare from the retail and finance sectors, which have flourished with their implementations of digital technologies. Changes in regulatory, patent and market trends will drive opportunities for generic drugs and hence very big opportunities for Indian pharmaceutical companicontinue reading